CRSP earnings date and last-quarter result: next report 2026-08-03, last quarter miss, P/E -7.59. Updated 2026-07-23.
CRISPR Therapeutics (CRSP) Research Hub
CRISPR Therapeutics (CRSP) trades on NASDAQ, CH in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 49.01 USD (-0.77%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -7.59, market cap 4.54B. This hub links to the full technical, earnings and options research available for CRSP.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, CH |
| Last close | 49.01 USD (-0.77%) |
| 52-week range | 45.89 USD – 63.45 USD |
| Trend regime | Range |
| 14-day RSI | 34.9 (Bearish) |
| Trailing P/E | -7.59 |
| Market cap | 4.54B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for CRSP
Covered Call on CRSP: how it works, illustrative setup around the real 49.01 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CRSP: how it works, illustrative setup around the real 49.01 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CRSP: how it works, illustrative setup around the real 49.01 USD price, max profit/loss, breakeven and when to use it. Educational.
CRSP technical analysis: range, last 49.01 USD, RSI 34.9, 52w range 45.89 USD–63.45 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is CRSP in?
CRISPR Therapeutics (CRSP) is classified under Healthcare (Biotechnology), listed on NASDAQ, CH.
Is CRSP in an uptrend or downtrend?
As of 2026-10-26, CRSP is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CRSP's trailing P/E ratio?
CRSP's trailing P/E is -7.59, with a market cap of 4.54B. See the earnings research page for full valuation detail.
When does CRSP next report earnings?
CRSP is next scheduled to report earnings on 2026-08-03.